Stockreport

Centessa Pharmaceuticals a new buy at B Riley on sleep disorders pipeline [Seeking Alpha]

Bristol-Myers Squibb Company  (BMY) 
Last bristol-myers squibb company earnings: 2/6 07:05 am Check Earnings Report
US:NYSE Investor Relations: bms.com/investors.html
PDF The firm has a $33 price target (~110% upside based on Sept. 18 close). Centessa has two orexin 2 receptor agonists in development: ORX750 in phase 1 for sleep-wake d [Read more]